1. The analysis of the primary endpoint in the Survaxm iib trial public protocol is at 142 (of 246) events (57%), not 180 (73%). (Interim analysis was at 71 events (of 246), not at 90). There is no way, imo, they did not already reach 57% because, even with the late surge of enrollment, the first 69 patients were enrolled by April 2023.
2. Clinicaltrials.gov for Survaxm was not “sloppy,” nor did MimiVax fail to update it. The expected primary completion date (if you even understand what that means, I’m not certain you do) was updated to August 18, 2024 immediately and promptly upon enrollment completion in February 2024, and that means the reporting date for the primary endpoint is one year later on August 18, 2025.
3. As is typical with these trials, and as I suspect your connections with BP should know, this trial had very slow enrollment the first 1.75 years than raced to the finish at barely over two years, thus blurring your ability to correctly project upcoming results.
4. The powering in the trial did not result in enrollment increases needing to be made, because eventing was happening faster than researchers predicted. For example, in late December 2024, the trial director thought they had “several” months until the interim would occur, instead it happened the very next month in January 2025 and interim results were then given a few weeks later on February 12, 2025.
5. On July 16, 2025, the principle investigator for the Survaxm trial stated they were still waiting for the curves to separate out.
6. They won’t wait to publish an article before updating, instead, they stated they will update the public at the next relevant milestone, and they promised to follow regulator guidelines for sharing info. This means they must follow the required reporting date of midnight August 18, 2025 (or earlier), or be fined over 10,000.00 per day, imo.
7. We are one week from the required reporting date, and they have not requested an extension.
Note, after a couple of my nonfinal drafts of this post, ex softened his position here.
Ex still seems to misunderstand (forgotten?) what primary completion date means and how closely MimiVax diligently updated it upon completing enrollment.